Lupusqol-FR is valid to assess quality of life in: Patients with systemic lupus erythematosus

Rheumatology (United Kingdom)

Volumn 51, Issue 10, 2012, Pages 1906-1915

  Devilliers, Hervé ^a,b   Amoura, Zahir ^c,d   Besancenot, Jean Francois ^a   Bonnotte, Bernard ^a   Pasquali, Jean Louis ^e,f   Wahl, Denis ^b,g   Maurier, Francois ^h   Kaminsky, Pierre ^g   Pennaforte, Jean Loup ⁱ   Magy Bertrand, Nadine ^j   Arnaud, Laurent ^c   Binquet, Christine ^b   Guillemin, Francis ^g,k  

^a DIJON UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e HÔPITAL CIVIL   (France)

^f CNRS UPR 9021   (France)

^g UNIVERSITY HOSPITAL OF NANCY   (France)

^h Department of Internal Medicine   (France)

ⁱ SERVICE DE DERMATOLOGIE   (France)

^j UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^k UNIVERSITÉ DE LORRAINE   (France)

more..

Author keywords

Outcome assessment; Psychometrics; Quality of life; Systemic lupus erythematosus

Indexed keywords

ANTIMALARIAL AGENT; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

ADAPTATION; ADULT; AGED; ARTICLE; BODY IMAGE; COHORT ANALYSIS; CULTURAL ANTHROPOLOGY; DISEASE DURATION; EMOTION; FATIGUE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; SHORT FORM 36; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SELF REPORT; SEVERITY OF ILLNESS INDEX; TRANSLATIONS;

EID: 84867113919     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kes165     Document Type: Article

References (37)

1. Wallace DJ, Hahn B, Dubois EL. Dubois' lupus erythematosus, 7th edn. Philadelphia: Lippincott Williams & Wilkins, 2006.
2. Alarcón GS, McGwin G Jr, Uribe A et al. Systemic lupus erythematosus in a multiethnic lupus cohort (lumina). XVII. Predictors of self-reported health-related quality of life early in the disease course. Arthritis Rheum 2004;51: 465-74.
3. Haupt M, Millen S, Janner M et al. Improvement of coping abilities in patients with systemic lupus erythematosus: a prospective study. Ann Rheum Dis 2005;64:1618-23.
4. Kuriya B, Gladman DD, IbaÑez D, Urowitz MB. Quality of life over time in patients with systemic lupus erythematosus. Arthritis Rheum 2008;59:181-5.
5. Sanchez ML, McGwin G Jr, Durán S et al. Factors predictive of overall health over the course of the disease in patients with systemic lupus erythematosus from the lumina cohort (LXII): use of the SF-6D. Clin Exp Rheumatol 2009;27:67-71.
6. Trupin L, Tonner MC, Yazdany J et al. The role of neighborhood and individual socioeconomic status in outcomes of systemic lupus erythematosus. J Rheumatol 2008;35:1782-8.
7. Lau CS, Mak A. The socioeconomic burden of SLE. Nat Rev Rheumatol 2009;5:400-4.
8. McElhone K, Abbott J, Teh LS. A review of health related quality of life in systemic lupus erythematosus. Lupus 2006;15:633-43.
9. Yee CS, McElhone K, Teh LS, Gordon C. Assessment of disease activity and quality of life in systemic lupus erythematosus-new aspects. Best Pract Res Clin Rheumatol 2009;23:457-67.
10. Leong KP, Kong KO, Thong BY et al. Development and preliminary validation of a systemic lupus erythematosus-specific quality-of-life instrument (SLEQOL). Rheumatology 2005;44:1267-76.
11. McElhone K, Abbott J, Shelmerdine J et al. Development and validation of a disease-specific health-related quality of life measure, the lupusqol, for adults with systemic lupus erythematosus. Arthritis Rheum 2007;57:972-9.
12. Doward LC, McKenna SP, Whalley D et al. The development of the L-QoL: a quality-of-life instrument specific to systemic lupus erythematosus. Ann Rheum Dis 2009;68:196-200.
13. McElhone K, Castelino M, Abbott J et al. The LupusQoL and associations with demographics and clinical measurements in patients with systemic lupus erythematosus. J Rheumatol 2010;37:2273-9.
14. Jolly M, Pickard AS, Wilke C et al. Lupus-specific health outcome measure for us patients: the LupusQoL-US version. Ann Rheum Dis 2010;69:29-33.
15. Jolly M, Pickard SA, Mikolaitis RA et al. LupusQoL-US benchmarks for US patients with systemic lupus erythematosus. J Rheumatol 2010;37:1828-33.
16. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40: 1725.
17. Karlson EW, Daltroy LH, Rivest C et al. Validation of a systemic lupus activity questionnaire (SLAQ) for population studies. Lupus 2003;12:280-6.
18. Devilliers H, Guillemin F, Besancenot JF et al. Validation transculturelle en langue franç aise du systemic lupus activity questionnaire. Rev Med Interne 2009;30:S376.
19. Leple' ge A, Ecosse E, Verdier A, Perneger TV. The French SF-36 health survey: translation, cultural adaptation and preliminary psychometric evaluation. J Clin Epidemiol 1998;51:1013-23.
20. Petri M, Kim MY, Kalunian KC et al. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 2005;353:2550-8.
21. Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine (Phila Pa 1976) 2000;25: 3186-91.
22. Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 1993;46:1417-32.
23. Mokkink LB, Terwee CB, Patrick DL et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol 2010;63:737-45.
24. Kaiser H. The application of electronic computers to factor analysis. Educ Psychol Meas 1960;20:141-51.
25. Horn JL. A rationale and test for the number of factors in factor analysis. Psychometrika 1965;30:179-85.
26. Cattell RB, Vogelmann S. A comprehensive trial of the scree and kg criteria for determining the number of factors. Multivariate Behav Res 1977;12: 289-325.
27. Jackson DL, Gillaspy JA, Purc-Stephenson R. Reporting practices in confirmatory factor analysis: an overview and some recommendations. Psychol Methods 2009;14: 6-23.
28. Schreiber JB, Nora A, Stage FK, Barlow EA, King J. Reporting structural equation modeling and confirmatory factor analysis results: a review. J Educ Res 2006;99: 323-38.
29. Andrich D. Application of a psychometric rating model to ordered categories, which are scored with successive integers. Appl Psychol Meas 1978;2:581-94.
30. Hays RD, Morales LS, Reise SP. Item response theory and health outcomes measurement in the 21st century. Med Care 2000;38:II28-42.
31. Rasch G. Probabilistic models for some intelligence and attainment tests. Chicago: University of Chicago Press, 1960.
32. Tennant A, Conaghan PG. The Rasch measurement model in rheumatology: what is it and why use it? When should it be applied, and what should one look for in a Rasch paper? Arthritis Rheum 2007;57:1358-62.
33. Smith RM, Schumacker RE, Bush MJ. Using item mean squares to evaluate fit to the Rasch model. J Outcome Meas 1998;2:66-78.
34. Smith EV Jr. Detecting and evaluating the impact of multidimensionality using item fit statistics and principal component analysis of residuals. J Appl Meas 2002;3: 205-31.
35. Bond TG, Fox CM. Applying the Rasch model: fundamental measurement in the human sciences, 2nd edn. Mahwah, NJ: Lawrence Erlbaum Associates, 2007.
36. Ware JE, Kosinski M, Keller SD. SF-36 physical and mental summary scales: a user's manual. Boston, MA: Health Institute, New England Medical Center, 1996.
37. Wright BD, Linacre JM. Reasonable mean-square fit values. Rasch Meas Trans 1994;8:370.